´ÙÁß¾Ï Á¶±â¹ß°ß ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : Á¾·ùº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2025-2030³â)
Multi Cancer Early Detection Market Size, Share & Trends Analysis Report By Type (Liquid Biopsy, Gene Panel, LDT & Others), By End Use (Hospitals, Diagnostic Laboratories), By Region, And Segment Forecasts, 2025 - 2030
»óǰÄÚµå : 1630982
¸®¼­Ä¡»ç : Grand View Research, Inc.
¹ßÇàÀÏ : 2024³â 12¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 125 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,950 £Ü 8,609,000
Unprintable PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,950 £Ü 10,055,000
Printable PDF (5-User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,950 £Ü 12,949,000
Printable PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

´ÙÁß¾Ï Á¶±â¹ß°ß(MCED) ½ÃÀå ¼ºÀå ¹× µ¿Çâ:

Grand View Research, Inc.ÀÇ ÃֽŠº¸°í¼­¿¡ µû¸£¸é, Àü ¼¼°è ´ÙÁß¾Ï Á¶±â¹ß°ß ½ÃÀå ±Ô¸ð´Â 2025³âºÎÅÍ 2030³â±îÁö ¿¬Æò±Õ 17%ÀÇ CAGRÀ» ±â·ÏÇϸç 2030³â±îÁö 28¾ï 6,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀûÀýÇÑ Ä¡·á¸¦ À§ÇØ ¾ÏÀ» Á¶±â¿¡ ¹ß°ßÇÒ ¼ö ÀÖ´Â È¿°úÀûÀÎ ¹æ¹ýÀ» Á¦°øÇØ¾ß ÇÒ Çʿ伺°ú ¾ÏÀÇ À¯º´·ü Áõ°¡ ¹× ´Ù¾çÇÑ Áúº´ À¯ÇüÀÌ ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Á¶±â Áø´Ü¿¡ ´ëÇÑ ¿ä±¸´Â Áúº´À» ½±°Ô °ü¸®ÇÏ°í »ç¸Á·üÀ» ³·Ã߸ç Àüü ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù.

´ÙÁß¾Ï Á¶±â¹ß°ß(MCED) °Ë»ç´Â ȯÀÚ°¡ ¹«Áõ»óÀÎ °æ¿ì¿¡µµ ü³» Á¾¾çÀ» ¹ß°ßÇÒ ¼ö ÀÖµµ·Ï ¼³°èµÇ¾ú½À´Ï´Ù. ¾Ï¿¡ °É·ÈÀ» °¡´É¼ºÀÌ ³ôÀºÁö ¿©ºÎ¸¦ ÆÇ´ÜÇϱâ À§ÇØ ¿©·¯ ½ÅÈ£¸¦ µ¿½Ã¿¡ Æò°¡ÇÕ´Ï´Ù. ¾ÏÀ» Á¶±â¿¡ ¹ß°ßÇϱâ À§ÇÑ °Ë»ç´Â ¸¹ÀÌ °³¹ßµÇ¾î ¿ÔÁö¸¸, MCED ½ºÅ©¸®´× °Ë»ç´Â ÃÖ±Ù ¹Ì±¹¿¡¼­ ½ÇÇè½Ç¿¡¼­ °³¹ßµÈ °Ë»ç·Î¼­´Â óÀ½À¸·Î ½Ç¿ëÈ­µÇ¾ú½À´Ï´Ù. ¿¹¸¦ µé¾î, 2022³â 7¿ù, GRAIL»çÀÇ Galleri°¡ ¼¼ÀÎÆ®·çÀ̽ºÀÇ Mercy¿¡¼­ LDT·Î »ç¿ë °¡´ÉÇÏ°Ô µÇ¾ú½À´Ï´Ù. ¶ÇÇÑ, MCED ½ºÅ©¸®´× °Ë»ç´Â Exact Sciences¿Í Freenome¿¡ ÀÇÇØ °³¹ßµÇ¾úÀ¸¸ç, GRAILÀÇ Galleri °Ë»ç´Â ÃÖ´ë 50°³ÀÇ ´Ù¸¥ À¯ÇüÀ» °ËÃâÇÒ ¼ö ÀÖ´Â °ÍÀ¸·Î º¸Çè Àû¿ëÀÌ µÇÁö ¾Ê´Â ºñº¸ÇèÀ¸·Î ÆÇ¸ÅµÇ°í ÀÖ½À´Ï´Ù.

¿¬±¸¿¡ µû¸£¸é, MCED °Ë»ç´Â Ä¡·á °¡´ÉÇÏ°í ¶§·Î´Â ¿ÏÄ¡°¡ °¡´ÉÇÑ Ãʱ⠴ܰ躸´Ù ¸»±â³ª ÁøÇà ´Ü°è¿¡ ´õ ¹Î°¨ÇÏ°Ô ¹ÝÀÀÇÏ´Â °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù. ¶ÇÇÑ, ÀÌ °Ë»ç´Â ƯÀ̼ºÀÌ ³ô¾Æ ¾ÏÀÌ ¾Æ´Ñ »ç¶÷ÀÌ ¾ç¼º ¹ÝÀÀÀ» º¸ÀÏ °¡´É¼ºÀº ¸Å¿ì ³·Àº °ÍÀ¸·Î ³ªÅ¸³µ½À´Ï´Ù. Á¶±â Áø´Ü¿¡ ´ëÇÑ ¼ö¿ä¸¦ ÃæÁ·½Ã۱â À§ÇØ MCED °³¹ß ºÐ¾ß´Â ÇöÀçµµ °è¼Ó ¿¬±¸µÇ°í ÀÖ½À´Ï´Ù.

½ÃÀå ¼±µµ ±â¾÷µéÀº 2-3°¡Áö ¾ÏºÎÅÍ 50°¡Áö ¾Ï±îÁö ½Äº°ÇÒ ¼ö ÀÖ´Ù°í ÁÖÀåÇϰí ÀÖ½À´Ï´Ù. °¢ ¾÷üµéÀº ÀÌ·¯ÇÑ ¼±º° °Ë»çÀÇ ¼ºÀå°ú °³¹ß, ±×¸®°í ºü¸¥ »ó¿ëÈ­¿¡ ÃÊÁ¡À» ¸ÂÃß°í ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, 2020³â 12¿ù Singlera Genomics´Â MCED °Ë»çÀÇ °³¹ß, ¸¶ÄÉÆÃ, È«º¸¸¦ À§ÇØ ½Ã¸®Áî B¿¡¼­ 1¾ï 5,000¸¸ ´Þ·¯ÀÇ ÀÚ±ÝÀ» Á¶´ÞÇßÀ¸¸ç, GRAILÀº Point32Health¿Í ÆÄÀÏ·µ ÇÁ·ÎÁ§Æ®¸¦ ½ÃÀÛÇß°í, Point32Health´Â MCED °Ë»ç°¡ Æ÷ÇÔµÈ Point32 Health´Â MCED °Ë»ç¸¦ Æ÷ÇÔÇÑ ÃÖÃÊÀÇ °Ç°­ °ü·Ã »ó¾÷Àû °èȹÀÌ µÇ¾ú½À´Ï´Ù.

´ÙÁß¾Ï Á¶±â¹ß°ß ½ÃÀå : ºÐ¼® °³¿ä

¸ñÂ÷

Á¦1Àå ºÐ¼® ¹æ¹ý¡¤¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ´ÙÁß¾Ï Á¶±â¹ß°ß(MCED) ½ÃÀå : º¯¼ö, µ¿Çâ, ¹üÀ§

Á¦4Àå ´ÙÁß¾Ï Á¶±â¹ß°ß(MCED) ½ÃÀå : Á¾·ùº° ÃßÁ¤°ú µ¿Ç⠺м®

Á¦5Àå ´ÙÁß¾Ï Á¶±â¹ß°ß(MCED) ½ÃÀå : ÃÖÁ¾ ¿ëµµº° ÃßÁ¤°ú µ¿Ç⠺м®

Á¦6Àå ´ÙÁß¾Ï Á¶±â¹ß°ß(MCED) ½ÃÀå : Áö¿ªº° ÃßÁ¤°ú µ¿Ç⠺м®

Á¦7Àå °æÀï ±¸µµ

KSM
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Multi Cancer Early Detection Market Growth & Trends:

The global multi cancer early detection market size is expected to reach USD 2.86 billion by 2030, registering a CAGR of 17% from 2025 to 2030, according to a new report by Grand View Research, Inc. The need for providing effective ways to detect cancer at an early stage so that the right treatment can be given and the rising prevalence of cancer and multiple forms are expected to fuel the growth of the market. The requirement for early detection diagnostics, which facilitates simple disease management and subsequently lowers the death rate, drives the overall market.

Multi cancer early detection (MCED) tests are designed to find tumors in the body even when a patient is asymptomatic. To determine whether there is a high probability that a person has cancer, they simultaneously evaluate several signals. Although numerous tests are being developed to detect cancer at an early stage, the first MCED screening test was just recently made available in the U.S. as a lab-developed test. For instance, in July 2022, GRAIL's Galleri was made available as an LDT at Mercy, St. Louis. Furthermore, MCED screening tests are being developed by Exact Sciences and Freenome, and GRAIL's Galleri test is being marketed without payer coverage with the claim that it can detect up to fifty different forms.

Studies show that MCED tests have a higher sensitivity for detecting later-stage or advanced than for detecting earlier stages, which are more treatable and occasionally curable. Additionally, it was found that the tests were highly specific, which made it extremely unlikely that they would give a positive result for someone who did not have cancer. To meet the demand for early diagnosis, ongoing research is still being done in the field of developing MCED.

The major players in the market assert that they can identify as few as two or three different cancer types or as many as fifty. They are focusing on the growth and development of these screening tests and faster commercialization. For instance, in December 2020, Singlera Genomics raised $150 million in Series B funding for the development, marketing, and promotion of its MCED tests. GRAIL launched a pilot project with Point32Health, making Point32Health the first commercial plan for health to include MCED tests.

Multi Cancer Early Detection Market Report Highlights:

Table of Contents

Chapter 1. Methodology and Scope

Chapter 2. Executive Summary

Chapter 3. Multi Cancer Early Detection (MCED) Market Variables, Trends & Scope

Chapter 4. Multi Cancer Early Detection (MCED) Market: Type Estimates & Trend Analysis

Chapter 5. Multi Cancer Early Detection (MCED) Market: End Use Estimates & Trend Analysis

Chapter 6. Multi Cancer Early Detection (MCED) Market: Regional Estimates & Trend Analysis

Chapter 7. Competitive Landscape

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â